Delivery Order SPE2DB24D1104-SPE2DB24FXZT4

Award Date 6/27/24
Potential Completion Date 6/28/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 21, 2024, with a ceiling value of $1,002.28 and a completion date of June 24, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
The federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $4,091.20 and is a Firm Fixed Price Delivery Order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The firm-fixed-price delivery order has a ceiling value of $1,176.22 and an ultimate completion date of March 11, 2025. The contract is not designated under a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,697.74 and is a delivery order for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract is a firm fixed-price agreement with an ultimate completion date of March 25, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award to Amerisourcebergen Drug Corp, a division of the major pharmaceutical distributor Amerisourcebergen Corporation, is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin medication, to the U.S. government. The contract has a ceiling value of $1,324.39 and is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This award is not associated with a set-aside program....
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication, to the Defense Logistics Agency (DLA), which is a defense agency under the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on a firm fixed-price basis for a ceiling value of $3,864.54. The award has an ultimate completion date of July 8, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The award has a ceiling value of $1,125.08 and an ultimate completion date of November 26, 2024. This contract is a delivery order issued under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical product to the Defense Logistics Agency (DLA), a defense agency under the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, which is fulfilling the contract through its Corporate Office division. The contract, valued at $5,970.84, is a firm-fixed-price delivery order with a completion date of June 3, 2024. It is not set...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a type of insulin medication. The contract has a ceiling value of $1,310.08 and is a Delivery Order contract with a Firm Fixed Price pricing type. The ultimate completion date is March 19, 2025. The contract is not designated as a set-aside....
This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,930.32 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), a leading global pharmaceutical sourcing and distribution services firm. The contract is a delivery order issued under an indefinite delivery contract...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FXZT4
    Delivery Order

This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a prescription insulin product, to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $2,147.93, was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distributor.

The contract is a Delivery Order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/26/24, 9:03 AM